PartX

Partex is a private AI-driven digital pharma company focused on drug discovery, development support, and drug asset management for the life sciences industry. The company positions itself as an AI-powered Drug Assets Manager, using large-scale public and proprietary biomedical data, artificial intelligence, and real-world data to identify assets, expand indications, enrich dossiers, and support in-licensing or out-licensing decisions. In addition to its platform business, Partex states that it has an in-house and partnered asset pipeline, with a particular emphasis on oncology and hematology and broader activity across immunology, CNS, cardiovascular, and metabolic diseases. Its customers and partners include biopharma companies, CROs, and academic organizations seeking faster and lower-cost development decisions. The company appears to operate more as a platform-enabled biotech and transaction/asset-enablement company than as a traditional single-asset therapeutics developer.